Rightway Secures $155M to Transform Pharmacy Benefits

NEW YORK, Sept. 24, 2026 /CourierPR/ -- Rightway, a pharmacy benefit management and care navigation company, has raised $155 million in a Series E financing led by Francisco Partners, a leading global investment firm that specializes in partnering with technology companies. The investment will support Rightway's next phase of growth as employers seek greater accountability for pharmacy spending and better support for their members. The company now counts 45 Fortune 500 companies among its clients, and its approach combines an aligned financial model that removes all incentives to profit from higher drug spend with a clinical model that puts pharmacists to work guiding members to the most appropriate medications at the lowest cost. Rightway's care navigation offering extends this model across healthcare, helping members find high-quality care and get more from their benefits. Plan sponsors partner with Rightway to deliver more value from every healthcare dollar for their organizations and their members.

Healthcare costs continue to rise faster than inflation, and prescription drugs are projected to be the fastest-growing major category of healthcare spending over the next decade. In 2025, prescription drug spending increased 9.4% among large U.S. employers, outpacing the 6% increase in overall health benefit costs. Employers are paying for bloated administrative overhead and a set of incentives that reward the middle of the supply chain when drug prices go up rather than down. Rightway's model offers one of the clearest opportunities to change that trajectory by managing costs more effectively while improving the care people receive.

Rightway backs its financial alignment with the SureSpend™ model. The Precision Pricing Guarantee sets a maximum on total pharmacy spend. The Zero-Markup Wrap covers categories commonly excluded from pharmacy spending guarantees, including GLP-1s and rare high-cost medications, at true net cost with 100% rebate pass-through. No one is better positioned to manage the pharmacy benefit than Rightway, according to Jordan Feldman, Rightway's Co-Founder and CEO. Rightway's approach blends expert clinical guidance, high-touch service, and intuitive technology to deliver personalized, evidence-based support that improves outcomes, drives engagement, and reduces costs.

Rightway will use the Series E financing to expand its AI capabilities and the technology that powers its pharmacy benefits model.

Ezra Perlman, Co-President at Francisco Partners, believes Rightway is well positioned to meet the demand for greater accountability, transparency, and value from their healthcare partners.

Rightway's approach to pharmacy benefits and care navigation is transforming the industry, offering a clear path to better care and lower costs for employers and their members. The company's financial alignment and clinical expertise are at the core of its success, and its technology and AI capabilities are driving further innovation. Rightway's mission is to help employers get more from one of their largest and fastest-growing healthcare expenses, making healthcare more affordable for companies and the people who work for them.